WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- In a new post-hoc analysis presented for the first time at the American Diabetes Association (ADA) 70 th Annual Scientific Sessions, significantly more ...
People who take a certain type of diabetes drug to lower blood sugar levels may be at an increased risk of developing an inflamed pancreas, according to a new study. Glucagonlike peptide 1(GLP-1) ...
Medically reviewed by Erika Prouty, PharmD Many medications can help people with diabetes manage their blood sugar. While ...
Can it be that Merck is going out looking for unexpected cardiovascular side effects? The drugmaker is preparing to launch a massive trial of its diabetes med Januvia, specifically to check for ...
CHICAGO, June 23 (Reuters) - Merck & Co.'s new diabetes pill, Januvia, improved blood sugar control when added to current therapies, according to data released on Saturday at a major medical meeting.
People who take a certain type of diabetes drug to lower blood sugar levels may be at an increased risk of developing an inflamed pancreas, according to a new study. Glucagonlike peptide 1(GLP-1) ...